Hypersensitivity reactions to procarbazine with mechlorethamine, vincristine, and procarbazine chemotherapy in the treatment of glioma

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Cancer

• Publication date

  1992-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19920515)69:10<2532::AID-CNCR2820691024>3.0.CO;2-IPMID 1568176
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.

  2009cited by this paper
• Procarbazine-induced skin reactions in Hodgkin's disease and other malignant lymphomas.

  2009cited by this paper
• MOPP regimen as primary chemotherapy for brain tumors in infants

  2004cited by this paper
• A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4

  1991cited by this paper
• Delayed Life‐Threatening Pneumonitis Secondary to Procarbazine

  1990cited by this paper
• Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure

  1990cited by this paper
• Pulmonary toxicity following MOPP chemotherapy.

  1990cited by this paper
• VP-16, vincristine and procarbazine with radiation therapy for treatment of malignant brain tumors

  1990cited by this paper
• Successful chemotherapy for newly diagnosed aggressive oligodendroglioma

  1990cited by this paper
• Cytotoxic drug-induced fever: a report on procarbazine-induced hyperpyrexia.

  1990cited by this paper
• Can MOPP be replaced in the treatment of advanced Hodgkin's disease?

  1990cited by this paper
• Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent high-grade glioma in adults: a phase II study.

  1990cited by this paper
• Acute toxicity from BOPP (BCNU, vincristine, procarbazine, cisplatinum) chemotherapy for glioblastoma multiforme.

  1990cited by this paper
• Pre-irradiation chemotherapy for infants and children with medulloblastoma: a preliminary report.

  1989cited by this paper
• Immunology and cellular biology of Hodgkin's disease.

  1989cited by this paper
• A personal communication

  1989cited by this paper
• Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

  1989cited by this paper
• Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors

  1989cited by this paper
• Pre-radiation chemotherapy for infants and poor prognosis children with medulloblastoma.

  1988cited by this paper
• Procarbazine hypersensitivity manifested as a fixed drug eruption.

  1988cited by this paper
• COPBLAM III: infusional combination chemotherapy for diffuse large-cell lymphoma.

  1988cited by this paper
• Chemotherapy induction, consolidation radiotherapy and maintenance alternating chemotherapy in small cell carcinoma of the lung.

  1988cited by this paper
• Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine.

  1988cited by this paper
• Successful chemotherapy for recurrent malignant oligodendroglioma

  1988cited by this paper
• Salvage chemotherapy for recurrent primary brain tumors in children.

  1988cited by this paper
• Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. A preliminary report

  1987cited by this paper
• Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.

  1987cited by this paper
• Combined intraarterial and systemic chemotherapy for intracerebral tumors.

  1987cited by this paper
• Metastatic malignant melanoma treated with procarbazine, vincristine and lomustine (POC).

  1987cited by this paper
• Phase I trial of procarbazine as a 5-day continuous infusion in children with central nervous system tumors.

  1987cited by this paper
• Use of trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonitis in patients with acquired immunodeficiency syndrome.

  1987cited by this paper
• Academic viability of general internal medicine.

  1986cited by this paper
• Procarbazine-induced interstitial pneumonitis with a normal chest x-ray: a case report.

  1986cited by this paper
• Cytotoxic chemotherapy of disseminated cutaneous malignant melanoma--a prospective and randomized clinical trial of procarbazine, vindesine and lomustine versus procarbazine, DTIC and lomustine.

  1986cited by this paper
• Randomized comparisons of radiotherapy and carmustine versus procarbazine versus dacarbazine for the treatment of malignant gliomas following surgery: a Southwest Oncology Group Study.

  1986cited by this paper
• Immunobiology of human gliomas.

  1986cited by this paper
• Twenty years of MOPP therapy for Hodgkin's disease.

  1986cited by this paper
• Phase II evaluation of procarbazine in metastatic breast cancer: a Southeastern Cancer Study Group Trial.

  1986cited by this paper
• Lomustine, vincristine, and procarbazine in the treatment of metastatic malignant melanoma.

  1985cited by this paper
• Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.

  1985cited by this paper
• Combination chemotherapy with vincristine (NSC-67574), procarbazine (NSC-77213), prednisone (NSC-10023) with or without nitrogen mustard (NSC-762)(MOPP vs OPP) in children with recurrent brain tumors.

  1984cited by this paper
• Combination cytotoxic chemotherapy with procarbazine, vincristine, and lomustine (POC) in disseminated malignant melanoma: 8 years' follow-up.

  1984cited by this paper
• Anticonvulsant Drugs

  1984cited by this paper
• Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy.

  1983cited by this paper
• Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.

  1983cited by this paper
• Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen.

  1982cited by this paper
• Toxicity and response criteria of the Eastern Cooperative Oncology Group

  1982cited by this paper
• Reasons for failure of MOPP to cure Hodgkin's disease The importance of dose and schedule

  1982cited by this paper
• Phenytoin hypersensitivity

  1979cited by this paper
• Chemotherapy of nonirradiated malignant gliomas. Phase II: Study of the combination of methyl‐CCNU, vincristine, and procarbazine

  1979cited by this paper
• Comparison of low dose radiation therapy alone or combined with procarbazine (NSC-77213) for unresectable epidermoid carcinoma of the lung, state T3, N1, N2, or M1.

  1978cited by this paper
• Combination chemotherapy of malignant glioma. Effect of postoperative treatment with CCNU, vincristine, amethopterine and procarbazine.

  1978cited by this paper
• Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine.

  1978cited by this paper
• Comparison of low dose radiation therapy alone or combined with procarbazine (NSC‐77213) for unresectable epidermoid carcinoma of the lung, stage t3, N1, N2, or ML

  1978cited by this paper
• Radiotherapy combined with procarbazine, bleomycin, and CCNU in the treatment of high-grade supratentorial astrocytomas.

  1978cited by this paper
• Combination chemotherapy with MOPP in children with recurrent brain tumors.

  1978cited by this paper
• Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients.

  1977cited by this paper
• Immunobiology of primary intracranial tumors.

  1977cited by this paper
• Combination chemotherapy with vincristine, adriamycin, and procarbazine in previously treated patients with small cell carcinoma.

  1977cited by this paper
• Hypersensitivity to procarbazine associated with angioedema, urticaria, and low serum complement activity.

  1976cited by this paper
• Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.

  1976cited by this paper
• Chemotherapy of malignant glioma with CCNU alone and CCNU combined with vincristine sulfate and procarbazine hydrochloride.

  1976cited by this paper
• Cyclophosphamide, vincristine and procarbazine in the treatment of malignant melanoma

  1976cited by this paper
• Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine

  1976cited by this paper
• BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors.

  1976cited by this paper
• Chemotherapy of malignant glioma with CCNU alone and CCNU combined with vincristine sulfate and procarbazine hydrochloride.

  1976cited by this paper
• Phase II study of vinblastine, adriamycin, and procarbazine in small cell carcinoma of the lung.

  1976cited by this paper
• Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors

  1975cited by this paper
• Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel.

  1975cited by this paper
• Combination chemotherapy in oat cell carcinoma of the lung

  1975cited by this paper
• Procarbazine hydrochloride in the treatment of brain tumors. Phase 2 study.

  1974cited by this paper
• Combination chemotherapy of advanced Hodgkin's disease.

  1973cited by this paper
• Combination chemotherapy of advanced Hodgkin's disease.

  1973cited by this paper
• Allergic reaction to procarbazine

  1972cited by this paper
• Hypersensitivity to procarbazine (Matulane®) manifested by fever and pleuropulmonary reaction

  1972cited by this paper
• Combination chemotherapy in the treatment of advanced Hodgkin's disease.

  1970cited by this paper
• The metabolism of blood serum glycoproteins in rats with experimental granuloma after glucosamine-1-14C injection.

  1968cited by this paper
• Hepatotoxicity of cytostatic drugs evaluated by liver function tests and appearance of jaundice.

  1968cited by this paper
• SODIUM DIPHENYL HYDANTOINATE IN THE TREATMENT OF CONVULSIVE DISORDERS

  1938cited by this paper

• Unlocking new horizons: advances in treating IDH-mutant, 1p/19q-codeleted oligodendrogliomas

  2025cites this paper
• Dermatological Toxicities of Chemotherapy

  2020cites this paper
• 14. Alkylating Agents

  2013cites this paper
• Life‐threatening (Serious) Dermatologic Adverse Events

  2013cites this paper
• A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas

  2012cites this paper
• Hypersensitivity to Procarbazine and Severe RSV Pneumonia in a Child with Hodgkin's Lymphoma

  2011cites this paper
• Principles of Chemotherapy

  2011cites this paper
• The Pulmonary Toxicity of Anticancer Agents

  2010cites this paper
• INCIDENCE OF HYPERSENSITIVITY REACTIONS

  2009cites this paper
• Chemotherapy and biotherapy-induced hypersensitivity reactions.

  2009cites this paper
• Hypersensitivity reactions to antineoplastic agents: an overview

  2009cites this paper
• Chemotherapy and biotherapy-induced hypersensitivity reactions.

  2009cites this paper
• Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.

  2009cites this paper
• The Effect of Enzyme-Inducing Antiseizure Drugs on the Pharmacokinetics and Tolerability of Procarbazine Hydrochloride

  2006cites this paper
• Hypersensitivity reactions to chemotherapeutic drugs

  2003cites this paper
• Pulmonary Toxicity Secondary to Procarbazine

  2002influential citation
• Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components.

  2000cites this paper
• Systemic inflammatory response syndrome associated with amifostine.

  2000cites this paper
• Mucocutaneous reactions to chemotherapy.

  1999cites this paper
• Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study.

  1999cites this paper
• Cystosarcoma phyllodes: the Western Australian experience.

  1999cites this paper
• Use of fluorescent probes to assess the early sulfhydryl depletion and oxidative stress induced by mechlorethamine in human bronchial epithelial cells.

  1999cites this paper
• Procarbazine a nd H igh-Dose T amoxifen a s a S econd-Line Regimen i n R ecurrent H igh-Grade G liomas: A P hase I I S tudy

  1999cites this paper
• CONTINUING MEDICAL EDUCATION Mucocutaneous reactions to chemotherapy

  1999cites this paper
• Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas.

  1998cites this paper
• Chemotherapy for aggressive or anaplastic high grade oligodendrogliomas and oligoastrocytomas: better than a salvage treatment.

  1998cites this paper
• Anticonvulsant usage is associated with an increased risk of procarbazine hypersensitivity reactions in patients with brain tumors

  1997cites this paper
• Early cytotoxic effects of mechlorethamine, a nitrogen mustard, on mammalian airway epithelium.

  1997cites this paper
• [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].

  1997cites this paper
• Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.

  1994cites this paper